.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
AstraZeneca
US Department of Justice
Boehringer Ingelheim
Cerilliant
QuintilesIMS
Julphar
Harvard Business School
Farmers Insurance

Generated: June 26, 2017

DrugPatentWatch Database Preview

Fresenius Company Profile

« Back to Dashboard

Summary for Applicant: Fresenius

Patents:19
Tradenames:202
Ingredients:148
NDAs:243
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Medcl
PHOSLO GELCAPS
calcium acetate
CAPSULE;ORAL021160-003Apr 2, 2001ABRXYesYes6,576,665► Subscribe ► Subscribe
Fresenius Kabi Usa
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
INJECTABLE;INJECTION087329-002Approved Prior to Jan 1, 1982APRXNoYes► Subscribe► Subscribe
Fresenius Kabi Usa
ASTRAMORPH PF
morphine sulfate
INJECTABLE;INJECTION071050-001Oct 7, 1986APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
HEPARIN SODIUM IN PLASTIC CONTAINER
heparin sodium
INJECTABLE;INJECTION017029-015Dec 5, 1985APRXYesYes► Subscribe► Subscribe
Fresenius Kabi Usa
POLOCAINE-MPF
mepivacaine hydrochloride
INJECTABLE;INJECTION089409-001Dec 1, 1986APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
Chubb
Cipla
Covington
Fuji
Queensland Health
Cantor Fitzgerald
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot